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Abstract We have studied the responses of honey bees at
different life stages (Apis mellifera) to controlled infection
with acute bee paralysis virus and have identiﬁed the
haemolymph of infected larvae and adult worker bees as
the compartment where massive propagation of ABPV
occurs. Insects respond with a broad spectrum of induced
innate immune reactions to bacterial infections, whereas
defence mechanisms based on RNA interference play a
major role in antiviral immunity. In this study, we have
determined that honey bee larvae and adult workers do not
produce a humoral immune reaction upon artiﬁcial infec-
tion with ABPV, in contrast to control individuals chal-
lenged with Escherichia coli. ABPV-infected bees
produced neither elevated levels of speciﬁc antimicrobial
peptides (AMPs), such as hymenoptaecin and defensin, nor
any general antimicrobial activity, as revealed by inhibi-
tion-zone assays. Additionally, adult bees did not generate
melanised nodules upon ABPV infection, an important
cellular immune function activated by bacteria and viruses
in some insects. Challenge of bees with both ABPV and
E. coli showed that innate humoral and cellular immune
reactions are induced in mixed infections, albeit at a
reduced level.
Introduction
Viral infection is a major burden for all eukaryotic
organisms. As a consequence, they possess efﬁcient
mechanisms to combat viral infections that differ in ver-
tebrates, insects and plants. For example, vertebrates
respond with the induction of cytokines of the interferon
family to viral RNAs in infected cells. Insects lack an
adaptive immune system. Instead, they rely on the innate
immune system, consisting of humoral and cellular
immune responses, and the activation of prophenoloxidase
by a serine protease cascade [12, 28, 33, 50]. Infection of
Drosophila with bacteria or fungi triggers a strong humoral
response that is mediated by two conserved signalling
cascades, the Toll and Imd pathways, both of which
regulate the transcription of target genes with conserved
NF-jB-like motifs. Transcription activation results in the
synthesis of antimicrobial peptides (AMPs) in the fat body,
followed by secretion of peptides into the haemolymph.
The cellular immune response is mediated by circulating
cells in the haemolymph called haemocytes that phagocy-
tose and encapsulate invading parasites.
The recent sequencing of the honey bee (Apis mellifera)
genome [26] revealed that honey bees possess homologues
of members of the Toll and Imd pathway implicated in
humoral immune responses [21]. Moreover, a number of
honey-bee-speciﬁc AMPs were biochemically character-
ized by Casteels-Josson et al. [11], and their in vivo
expression was conﬁrmed in bee larvae and adult workers
after bacterial challenge [41]. Although a considerable
amount of information is available about humoral defence
reactions in bees directed against bacterial and fungal
infections, antiviral mechanisms in this social insect are not
known at all. Studies in the fruit ﬂy Drosophila and in
mosquitos (Aedes aegypti and Anopheles gambiae) have
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mechanism based on RNA interference plays a major role
in antiviral immune responses against single-stranded and
double-stranded RNA viruses [3, 23, 29, 44, 51, 53, 54, 57],
whereas reports about the signiﬁcance of inducible antiviral
reactions are somehow contradictory. Sabatier et al.[43] did
not detect any of the known AMPs in the haemolymph of
Drosophila ﬂies challenged with drosophila C virus (DCV)
(a member of the family Dicistroviridae). Likewise, injec-
tion of cricket paralysis virus (CrPV) into the haemocoel of
adult Drosophila ﬂies did not trigger the synthesis of spe-
ciﬁc AMPs that are known to be induced either by the Toll
or the Imd signalling pathway, indicating the absence of
humoral immune reactions to the two dicistroviruses. On
the other hand, when CrPV was injected into isogenic
mutants of the Imd signalling cascade, the ﬂies displayed an
increased sensitivity to CrPV infection and higher virus
loads, suggesting that the Imd pathway is involved in the
antiviral immune response, possibly by distinct branches
[15]. Additionally, it was demonstrated by Dostert et al.
[19] that several genes controlled by the JAK/STAT path-
way were speciﬁcally up-regulated upon DCV infection.
Furthermore, the induction of the Toll pathway has been
identiﬁed as an important antiviral response in Drosophila
upon infection with drosophila X virus [56] and in Aedes
aegypti in dengue virus infection [55]. More recent studies
have revealed a dual function of a member of the Dicer
family. In addition to its involvement in RNA interference,
the DExD/H-box helicase Dicer-2 has been shown also to
regulate the induction of a protein (Vago) that controls viral
load in some tissues of Drosophila [16].
In this report, we have examined the response of honey
bee larvae and adult workers upon infection with acute bee
paralysis virus (ABPV). This bee virus was originally
regarded as a picorna-like virus but has recently been
assigned to the new family Dicistroviridae [14]. ABPV has
a single-stranded positive-sense polyadenylated RNA
genome of 9.491 nucleotides. The genome consists of two
open reading frames (ORFs) separated by an intergenic
region. ORF1 encodes the non-structural proteins helicase,
3C-protease and RNA-dependent RNA polymerase, while
ORF2 encodes four capsid proteins [25; Fig. 1A]. The
structure of dicistrovirus capsids shows similarities to
vertebrate non-enveloped picornaviruses, but with some
intriguing differences [49]. ABPV was discovered as an
inapparent infection of adult bees by Bailey et al. [5]. In
contrast to the observed low impact of ABPV infections on
the survival of bee colonies for many years, shortly after
the introduction of the varroa mite (Varroa destructor)t o
Europe, ABPV was linked to the high mortality of colonies
infested with this ectoparasite [24].
Here, we show (i) that bee larvae respond with a sudden
deadly collapse after artiﬁcial infection with ABPV,
accompanied by an extreme retardation of weight gain and
a remarkable change of appearance, (ii) that ABPV propa-
gation in larvae and adults can be monitored by observing
viral capsid protein accumulation in the haemolymph of
infected individuals, and (iii) that neither humoral nor
cellular immune responses are induced or markedly sup-
pressed after ABPV infection of bee larvae and adults.
Materials and methods
Bacterial strains and media
The Gram-negative bacterium Escherichia coli (DSM 682)
was obtained from the Deutsche Sammlung von Mirkoor-
ganismen and Zellkulturen GmbH (DSMZ, Braunschweig),
and the Gram-positive bacterium Micrococcus ﬂavus was a
gift from Dr. U. Rdest (Institute of Microbiology, Bio-
centre, Wu ¨rzburg). The E. coli strain was cultivated in NB
medium (5 g nutrient broth, 5 g Bacto peptone and 10 g
NaCl per liter), whereas M. ﬂavus was grown in LB
medium (5 g Bacto yeast extract, 10 g Bacto tryptone and
10 g NaCl per liter). All ingredients were purchased from
Becton Dickinson (Heidelberg, Germany). For infection
experiments, E. coli bacteria were grown to an absorbance
of A550 = 0.5 (*3 9 10
8 cells/ml). After centrifugation at
5200 rpm for 5 min (Eppendorf 5417R), cells were washed
two times and resuspended in phosphate-buffered saline
(PBS) at the desired concentration.
Preparation of ABPV suspensions
A single highly puriﬁed virus suspension prepared at the
CVUA laboratory (Freiburg, Germany) served as a source
of acute bee paralysis virus (ABPV). For virus propaga-
tion, an ABPV suspension was injected into the haemo-
coel of white-eyed worker pupae of honey bees (Apis
mellifera). The infected pupae were maintained in an
incubator at 35C for 3 days. Thirty bee pupae were
crushed in 40 ml of 0.01 M potassium phosphate buffer,
pH 7.2 (PPB), 2 ml diethyldithiocarbamic acid and 1 ml
chloroform. The mixture was passed through cotton
gauze, centrifuged at 4000 rpm for 30 min and incubated
at 4C for 16 h. The supernatant was centrifuged at
24,000 rpm for 4.5 h in a Beckman SW41 rotor. The
precipitated virus was resuspended in 1 ml PPB, layered
on a 10-40% (w/v) sucrose gradient and centrifuged at
21,000 rpm for 3 h in a Beckman SW28 rotor. The virus
fraction was recovered, layered on a 30-60% (w/v) CsCl
gradient and centrifuged at 40,000 rpm for 18 h in a
Beckman SW41 rotor. The virus-enriched fraction was
dialyzed against PPB. The concentration of ABPV in the
puriﬁed preparation was A260 = 5.0, corresponding to
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1231 mg/ml [6] and equivalent to about 10
12 particles/ml
[22]. The A260/A280 ratio was 1.7. RT-PCR analysis
revealed the complete absence of sacbrood virus (SBV)
and minor contaminations by deformed wing virus
(DWV) in the ABPV preparation.
Origin of honey bee larvae and adults
During the summer seasons of 2008 to 2010, worker honey
bee larvae and adult bees were obtained each year from two
colonies with sister queens of Apis mellifera carnica
maintained in the BEEstation (University of Wu ¨rzburg).
For our studies, only healthy bee colonies were selected
that were free of chalk brood and American foulbrood and
in which infestation with the Varroa mite had been kept at
a low level by a professional beekeeper.
In vitro rearing of worker bee larvae and septic
wounding
Larvae were collected from a comb with a special grafting
tool and transferred to a 24-well tissue culture plate ﬁlled
with 300 ll of basic diet, consisting of 4.2 g freeze-dried
royal jelly powder, 0.6 g fructose, 0.6 g glucose, 0.2 g
Difco yeast extract and 14.4 ml sterile deionised water
according to Peng et al. [40]. The larvae were maintained
in an incubator (Memmert, HCP108) at 35 C and 70%
relative humidity. Each day, they were transferred to new
tissue culture plates ﬁlled with fresh nutrients. As deter-
mined previously, larval weight is a useful index of age
[41]. For artiﬁcial infection with ABPV or E. coli, fourth-
instar larvae with an average weight of 40-60 mg were
employed. The larvae were injected dorsally with either
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Fig. 1 Genomic mapping of ABPV capsid proteins.( A) Schematic
diagram of the genome of ABPV, which is classiﬁed as a dicistro-
virus. The numbers represent nucleotide positions according to Govan
et al. [25]. ORF1 encodes a helicase, a 3C-protease and an RNA-
dependent-RNA polymerase (RdRp), whereas ORF2 encodes the four
capsid proteins. The intergenic region (IGR) between the two ORFs
acts as an internal ribosomal entry site (IRES). Roman numbers
indicate processing sites. A puriﬁed ABPV suspension was separated
in a 10% (B) or 15% PAA/0.1% SDS gel (C). The gel was stained
with Coomassie blue G250. Arrows specify the viral capsid proteins
VP1 to VP4. (D) Capsid proteins were excised from the gel, and their
peptide composition was determined by MS/MS analysis after in-gel
digestion with trypsin. The bracket (*) denotes a peptide fragment
derived after cleavage of VP1 with protease V8. The black arrow
points to the presumed translation initiation site [39]. Triangles
signify putative cleavage sites within the capsid precursor [18, 25].
The amino acid sequence of the capsid precursor protein shown in
(D) is almost identical to the ABPV strain ‘‘Germany 2’’
(gi|19068035) described by Bakonyi et al. [7]. Underlined amino
acids indicate variable positions (colour ﬁgure online)
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1231 ll of phosphate-buffered saline (PBS) or with 1 llo f
appropriate amounts of E. coli cells and ABPV particles as
described [41] and as indicated in the legend to ﬁgures.
In vitro challenge of adult bees with viruses
and bacteria
Freshly emerged bees were obtained from a caged comb
placed in an incubator at 35 C about 20 days after the
deposition of eggs by a queen conﬁned on a comb without
brood. For each series of experiments, the collected young
worker bees were divided in 4 to 6 groups, one of which
was kept as an untreated control group. The remaining bees
were anesthetized by chilling on ice, and subsequently,
volumes of 1 ll of buffer (PBS), bacteria (E. coli) or virus
(ABPV) were injected laterally between the second and the
third tergit into the haemocoel. For injection, disposable
calibrated (1-5 ll) glass capillaries (Servoprax, Harten-
stein, Wu ¨rzburg) with ﬁne tips were utilized. The bees of
each group (10 to 20 individuals) were kept in small metal
boxes supplied with 45% (w/v) sucrose solution in an
incubator at 35 C until haemolymph collection.
Haemolymph collection
At the indicated times after septic and aseptic wounding,
all challenged larvae or adult bees were bled by puncturing
the abdomen with a ﬁne-tipped glass capillary (see above).
The collected haemolymph was transferred to reaction
tubes containing mixtures of N-phenylthiourea (PTU) and
aprotinin as described [41]. The samples were kept at -20
C until further analysis.
Inhibition-zone assay
An aliquot (0.2 ml) of a fresh overnight bacterial culture
was spread onto agar plates (Ø 9 cm) containing NB or LB
medium. The test bacteria were either E. coli 682 (Gram-
negative) or M. ﬂavus (Gram-positive). As soon as the
bacterial layer had been adsorbed, 1.5 ll of undiluted
haemolymph samples were applied as a droplet onto the
plates with a pipette tip. After 24 h of incubation in an
incubator at 37 C, the clear zones of inhibition were
documented by photography against a dark background.
Assays for nodulation reactions
We assessed nodule formation in adult bees (ten individ-
uals per group) at 6 and 24 h after injection with E. coli
cells and ABPV particles, respectively. A total of three
series of experiments were carried out. Before analysis, the
bees were embedded in parafﬁn (Histosec, Merck, Ger-
many). The dorsal abdominal tergits were carefully
removed, and the melanised, darkened nodules were
counted under a stereomicroscope (Olympus SZX7). After
initial counting, the alimentary canal was removed, and
nodules in the remaining internal tissue were also counted.
SDS polyacrylamide gel electrophoresis
One-dimensional gel electrophoresis was carried out in
vertical polyacrylamide slab gels containing 0.1% SDS
with a 5% stacking gel on top of the separation gel [32].
Haemolymph samples (1-1.5 ll) were diluted with 29
concentrated sample buffer, heated for 3 min at 95 C and
subjected to electrophoresis at constant voltage (120 V).
As a rule, 10% and 15% polyacrylamide gels were run in
parallel with the same haemolymph samples. For an even
better resolution of small proteins, the PAGE system of
Scha ¨gger and von Jagow [46] was employed with some
modiﬁcations [41]. After electrophoresis, gels were ﬁrst
ﬁxed for 30 min in 0.85% o-phosphoric acid/20% metha-
nol followed by colloidal Coomassie blue G250 staining
overnight in a solution of Roti
-Blue (Roth, Karlsruhe,
Germany) and 20% methanol. Gels were destained in 25%
methanol.
MS analysis and protein identiﬁcation
Stained protein bands were excised from the gel and sub-
jected to in-gel digestion with trypsin. Protein identiﬁcation
by nano LC-ESI-MS/MS analysis, and an NCBI nr protein
database search was performed by Proteome Factory AG,
Berlin, Germany.
Results
Characterization and genomic mapping of ABPV
capsid proteins
Phylogenetic analysis of ABPV strains of different geo-
graphic origin by RT-PCR assays revealed the close
genetic relationship between ABPV samples from different
European countries [7]. The ABPV strain from the UK
(Fig. 1A) that was employed for genome sequence analysis
by Govan et al. [25] served as a reference. First, we
established the German origin of the virus sample used in
our studies, and then we conﬁrmed and expanded the
genomic mapping of ABPV capsid proteins. Separation of
the virus preparation in either 10% or 15% denaturing
polyacrylamide gels revealed a total of four capsid proteins
of approximately 36, 33, 27 and 7.5 kDa (Fig. 1B, C) that
were numbered VP1 to VP4 in decreasing order of their
size [25]. The four protein bands were excised from the
gels and characterized as true ABPV capsid proteins by
692 K. Azzami et al.
123subsequent MS/MS analysis. Figure 1D shows a summary
of tryptic peptides that were identiﬁed in each of the four
capsid proteins in a total of ﬁve independent analyses. The
amino acid sequences revealed that the ABPV strain used
in our studies is nearly identical to the Germany 2 strain
characterized by Bakonyi et al. [7]. The N-terminal
sequences of VP2 and VP3 were recently determined by
Edman degradation [25] and are indicated by red and blue
arrowheads in Fig. 1D. The smallest capsid protein, VP4,
had not yet been mapped within the ORF2 region, but our
tryptic peptide analysis of the gel-excised VP4 capsid
protein clearly indicated its genomic location between VP1
and VP2 (Fig. 1A, D). The cleavage site between VP1 and
VP4 was tentatively assigned to be located between pep-
tide sequences VTMQ and INSK by comparison with
putative cleavage sites of related dicistroviruses [18, 52].
We were unable to identify the N-terminal sequence of
VP1 by Edman degradation, possibly because VP1 has a
blocked N-terminus. Hence, we could not conﬁrm that
initiation of translation of the polyprotein encoded in
ORF2 starts at the alanine (position 11, illustrated in
Fig. 1D) as suggested by several authors [9, 18, 30, 39].
However, it should be pointed out that digestion of ABPV
capsid protein VP1 with protease V8 revealed a long
peptide in the N-terminal region of VP1, indicating that
initiation of translation starts upstream of the glutamate
codon at position 14 (Fig. 1D).
Dose-dependent response of bee larvae and adults
to ABPV infection
In the original description of ABPV by Bailey et al. [5],
adult honey bees were challenged with the virus in three
different ways, i.e., by feeding, spraying, and artiﬁcial
injection of an ABPV suspension. The LD50 (number of
ABPV particles per bee that would have killed half of the
bees in a group after 6 days) was equivalent to about 10
2
when preparations were injected into the haemocoel com-
pared to more than 10
11 particles per bee by feeding and
10
8 to 10
9 particles per bee by spraying, indicating the high
virulence of ABPV upon injection.
We ﬁrst determined the response of newly emerged
adult worker bees to serial dilutions of our ABPV sus-
pension upon application into the haemocoel. As controls,
we used uninfected bees and bees that were treated with
10
5 viable E. coli cells. We have previously shown that
challenge of young adult bees (1-2 days old) with this high
dose of E. coli cells (i) has no deleterious effect on bees
and (ii) results in a pronounced stimulation of the humoral
immune response, as deduced from the expression of
antimicrobial peptides (AMPs) and immune-responsive
proteins [41]. Furthermore, it was demonstrated by Bedick
et al. [8] that newly emerged adult workers respond to
bacterial challenge with strong nodule formation, indicat-
ing that cellular immune reactions are also activated in
young bees. Almost all individuals of these two control
groups survived the maintenance in small cages up to 48 h,
and about 84% and 94%, respectively, were still alive after
72 h (Table 1). Dilution of the ABPV suspension by 10
-7
prior to injections of 1-ll samples (containing *10
2 virus
particles) did not have a pronounced effect on the survival
rate or on the pathological symptoms of the infected bees.
They looked healthy even at prolonged culture times
(C96 h). Quite in contrast, injection with 10
3 and 10
4 virus
particles had a severe impact on both the pathological
effects and the survival rate of infected individuals. None
of the bees were alive at 72 h p.i. (Table 1). Bees were
regarded as ‘‘dead’’ when they were motionless and had
turned on their backs. Symptoms of beginning paralysis,
i.e., trembling of wings and bodies of affected bees
occurred between 18 and 48 h, depending on the dilution
of ABPV. No or only a few bees survived after the
application of *10
4 ABPV particles, and about 60% were
still alive after 48 h upon infection of *10
3 virus particles
(Table 1).
Next, we studied the response of fourth-instar larvae to
ABPV infection. At this developmental stage, i.e., four
days after hatching, bee larvae have an average weight of
30 to 40 mg and survive aseptic and septic wounding to a
great extent [41]. As shown in Table 2, injection of 10
5
E. coli cells resulted in 80 to 90% survival of bee larvae
24 h p.i. A similar survival rate was observed if larvae
Table 1 Survival [%] of newly emerged adult worker bees upon artiﬁcial infection with E. coli and ABPV
Time (h) p.i. Uninfected
a E. coli
a 10
5 cells ABPV
a
10
4b 10
3b 10
2b
24 100 ± 09 9 ± 1.7 54.3 ± 27.7 82.7 ± 30 98.3 ± 2.9
48 100 ± 0 95.3 ± 4.5 6.3 ± 6.5 56.7 ± 24.5 95.3 ± 4.5
72 93.7 ± 3.2 83.7 ± 3.8 0 0 91 ± 6.6
Each group consisted originally of 25 individuals kept together in small cages in an incubator at 35 C
a The results show the mean ± standard deviation (SD) of three independent series of experiments
b Number of injected ABPV particles per bee
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123were challenged with 10
1 ABPV particles per larva.
No larvae survived injections of *10
3 ABPV particles,
whereas about 50% of larvae were alive 24 h after injection
of *10
2 ABPV particles.
ABPV accumulates in the haemolymph of bee larvae
and adults
Young adult worker bees injected with relatively small
doses of ABPV (approximately 10
3 virus particles per bee)
developed ﬁrst signs of trembling and paralysis as early as
18 h post-injection and died one or two days later
(Table 1). We have studied the time course of virus
propagation by collecting haemolymph samples from adult
bees at different times post-injection with different
amounts of ABPV particles and have analysed the total
protein patterns by SDS-PAGE. In newly emerged worker
bees (1-2 days old), apolipophorin (ApoLp)-I and -II (the
latter lacking the N-terminal amino acids 1 to 747),
transferrin and imaginal disc growth factor 4 (IDGF-4) are
prominent haemolymph proteins, whereas expression of
vitellogenin is still low at this early developmental stage
[41]. Upon infection with ABPV, little change in the
overall protein pattern was observed between 6 and 24 h
p.i. as compared to haemolymph samples derived from
uninfected and mock-infected (PBS) individuals, with the
exception of three novel major proteins that were present in
approximately equal amounts and were visible only in
samples collected from ABPV-infected bees. The migra-
tion of two of these coincided with the ABPV capsid
proteins VP2 and VP3, whereas the third one migrated
more slowly than the expected capsid protein VP1
(Fig. 2A). We eluted the corresponding protein bands from
the gel and conﬁrmed the viral origin of VP2 and VP3 by
subsequent MS/MS analysis. The amino acid sequence
coverage ranged from 27% (VP2) to 61% (VP3) for the
viral capsid proteins. Signiﬁcant amounts of bee-speciﬁc
proteins that migrated to a position similar to that of VP3
were identiﬁed as ferritin 1 (gi|110762641) and ferritin 2
(gi|66524161). The third virus-speciﬁc protein was char-
acterized as a precursor capsid protein composed of VP1
and VP4. This feature explains why we did not detect
visible amounts of VP4 in 15% PAA gels (not shown). MS/
MS analysis of the VP1/VP4 precursor revealed exclu-
sively VP1-derived peptides (up to 31% sequence cover-
age) in all analyses, as well as the VP4-speciﬁc peptide
IGSVAAIFG, but never peptides originating from VP2 or
VP3. The three ABPV-derived capsid proteins could be
ﬁrst detected 12 h p.i. in some individuals challenged with
*10
4 particles and were clearly visible 18 h and 24 h p.i.
in all bees infected with either 10
3 or 10
4 ABPV particles
(Fig. 2A), corresponding to the ﬁrst signs of pathological
effects in infected bees (Fig. 2B). At prolonged incubation
times, the sick bees became extremely desiccated so that it
was impossible to collect sufﬁcient haemolymph samples
for further protein analysis. Another picture emerged if
worker bees were challenged with only 10
2 ABPV parti-
cles. The haemolymph protein pattern remained essentially
constant up to 96 h p.i., and virus-speciﬁc capsid proteins
could not be detected (Fig. 2C), correlating with a high
survival rate of the infected bees (Fig. 2D).
The time course of ABPV multiplication was also
studied in haemolymph samples from infected bee larvae
from 6 to 24 h p.i. The haemolymph protein pattern of
fourth- and ﬁfth-instar larvae differs considerably from that
of young adult bees: in addition to ApoLp-I/ ApoLp-II and
transferrin, four classes of hexamerins (i.e., hexamerin 110,
hexamerin 70a, hexamerin 70b and hexamerin 70c) and a
very-high-density lipoprotein (VHDL) constitute the bulk
of larval haemolymph proteins [41]. Upon infection with
*10
3 ABPV particles per larva, the three capsid proteins
VP1/VP4, VP2 and VP3 were detected simultaneously in
the haemolymph of infected larvae as early as 9 h p.i., and
their production increased up to 24 h p.i. No virus-speciﬁc
capsid proteins were visible in larvae infected with only
10
1 ABPV particles (Fig. 3A), which correlates well with
the healthy appearance of these larvae and a high survival
rate (Fig. 3B, C). Uninfected larvae and larvae challenged
with 10
1 ABPV particles gained weight from about 45 mg
at the time of injection (i.e., fourth instar stage) to about
95 mg per larva upon haemolymph collection at 24 h p.i.
(Fig. 3B). Quite another image emerged if larvae were
Table 2 Survival (%) of fourth-instar bee larvae 24 h post-injection with E. coli and ABPV
Series of experiment Uninfected E. coli 10
5 cells ABPV
10
3b 10
2b 10
1b
I (2008) 100 (14/14)
a 80 (12/15) 0 (0/12) 53 (8/15) 81 (13/16)
II (2008) 91 (10/11) 83 (10/12) 0 (0/17) 39 (7/18) 75 (15/20)
III (2009) 100 (12/12) 90 (9/10) 0 (0/22) 50 (6/12) 91 (10/11)
Mean ± SD 97 ± 5.2 84.3 ± 5.1 0 47.3 ± 7.4 82.3 ± 8.1
a Number of survivors in relation to total number of individuals
b Number of injected ABPV particles per larva
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123challenged with *10
3 ABPV particles. All of them were
dead at 24 h p.i. (Fig. 3B) and exhibited a severe weight
retardation (49 ± 5.7 mg per larva) combined with a
change in colour from yellowish-white (Fig. 3B, larvae 13
and 18) to brownish-black (Fig. 3B, larvae 12 and 17) as
compared to healthy control larvae. The haemolymph
protein pattern likewise changed dramatically. Up to 12 h
p.i., it remained rather unaltered although ABPV had
already multiplied to a great extent, but thereafter, a
striking change in the overall protein composition could be
observed: many proteins that are related to translation,
energy metabolism, antioxidant protection or stress
response (Table S1) had been induced or up-regulated
(Fig. 3A, lane 18). Finally, larval collapse was accompa-
nied by an almost complete degradation of the major
haemolymph proteins, such as hexamerin 70a and hex-
amerin 70b (Fig. 3A, lane 17; Table S1).
Humoral immune response is not induced in bee larvae
or adults upon ABPV infection
We have previously studied the defence reactions of honey
bee larvae and adults to bacterial infections and have
presented evidence that insects at both of these develop-
mental stages respond with a pronounced humoral reaction
to challenge with E. coli, as documented by the transient
synthesis of the three antimicrobial peptides (AMPs)
hymenoptaecin, defensin1 and abaecin [41]. In the present
study, we ﬁrst compared the reactions of bee larvae and
adults to single infections with E. coli and ABPV.
Fourth-instar larvae were divided in four groups, each
consisting of ten individuals: one group was left untreated
(n.i.), one group was mock-infected (PBS), one group was
challenged with 10
5 viable E. coli cells, and the fourth
group was artiﬁcially infected with *10
3 ABPV particles.
All larvae were kept in tissue culture plates ﬁlled with fresh
nutrients in an incubator at 35 C for 24 h. At this time, the
haemolymph was collected, and aliquots of the same
sample were employed for protein analysis and inhibition-
zone assays. As expected, the three known AMPs, i.e.,
hymenoptaecin, defensin1 and abaecin, were induced in
bee larvae after bacterial infection; however, none of these
AMPs were expressed upon challenge with *10
3 ABPV
particles, as visualized in 15% PAA / 0.1% SDS gels
(Fig. 4A). Proteins of apparent similar size to hymenop-
taecin were eluted from the gel (lane 8; no. 11), and sub-
sequent MS/MS analysis revealed the absence of
hymenoptaecin and the presence of two newly induced
proteins annotated as heat shock protein 10 kD and thio-
redoxin-2 (Table S1). In addition, the presence or absence
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Fig. 2 Time course of ABPV multiplication in the haemolymph of
infected adult worker bees. Newly emerged worker bees (1-2 days
old) were either kept untreated (n.i.), mock-infected with PBS or
challenged with 10
2,1 0
3 or 10
4 ABPV particles. Haemolymph
samples were collected between 6 and 24 h p.i. (A) or between 24 and
96 h p.i. (B) from a total of ﬁve individuals (replicates) per group
followed by protein analysis and inhibition-zone assays. The analyses
of 1-2 replicates are shown. Aliquots of 1.5 ll (out of *8 ll) were
applied to a 10% PAA/0.1% SDS gel, and 1.5-ll aliquots of the same
sample were applied directly to agar plates together with M. ﬂavus as
indicator bacteria. As a positive control, lysozyme (L) was used at a
concentration of 5 lg/ll. Newly synthesized ABPV-speciﬁc capsid
proteins are indicated by red arrowheads. As a control, an aliquot of
7 ll of the undiluted ABPV suspension (1 mg/ml; *10
12 virus
particles/ml) was loaded onto the gel. The survival rate (%) of ABPV-
infected adult bees was monitored throughout the short-time (A) and
the long-time (B) experiment. The numbers in brackets represent the
number of survivors in relation to the total number of individuals. The
total number of bees decreased with prolonged incubation times
because ﬁve individuals were removed from each group at the
indicated times (p.i.) for subsequent protein and inhibition-zone
assays (colour ﬁgure online)
Immune response to acute bee paralysis virus 695
123Time [h] p.i. n.i. ABPV 103 ABPV 101
6
9
12
24
100 (14/14) 
100 (11/11)
89 (8/9) 
83 (5/6)
100 (28/28)
100 (25/25) 
33 (7/21) 
0 (0/17)
96 (26/27) 
96 (23/24)
80 (16/20)
75 (12/16)
A
116
67
45
35
25
6 h p.i.                   9 h p.i.                              12 h p.i.                     24 h p.i.
ABPV   ABPV           ABPV    ABPV                        ABPV    ABPV                    ABPV    ABPV 
[kDa]  n.i.      103           101         n.i.     103            101  ABPV   n.i.     103             101        n.i.              103             101 ABPV
VP 1
VP 2
VP 3
ApoLp-I
VHDL
Hex 110
ApoLp-II
Transferrin/
Hex 70a
Hex70b/70c
IDGF-4
VP 1/4
VP 2
VP 3
VP 1
1      2      3     4     5     6      7     8     9    10      L    11    12   13   14   15   16              17   18    19  20
1
2
3
4
5
6
7
8
9
10
B
6 h
12 h
24 h
1
2
3
4
5
16
17
18 19
13 12
11 15
14
n.i.           ABPV 103       ABPV 101
95 ± 2.6           49 ± 5.7           92 ± 2.5
79 ± 11           42 ± 8.3           77 ± 5.3
81 ± 2.4           56 ± 4.7           68 ± 2.9
Fig. 3 Time course of ABPV multiplication in the haemolymph of
infected bee larvae. Fourth-instar larvae were either left untreated
(n.i.) or challenged with 10
1 or 10
3 ABPV particles. Haemolymph
samples were collected between 6 and 24 h p.i. from a total of 3 to 4
individual larvae per group, followed by protein analyses and
inhibition-zone assays. The analyses of 1-2 replicates are shown
(A). Aliquots of 1 ll (out of *20 ll) were applied to a 10% PAA/
0.1% SDS gel, and 1.5 ll of the same sample was applied directly to
agar plates together with M. ﬂavus as indicator bacteria. Newly
synthesized ABPV-speciﬁc capsid proteins are indicated by red
arrowheads. The development of non-infected (n.i.) and ABPV-
infected in vitro cultured larvae up to 24 h p.i. is shown in (B). Larval
weight (mg) is expressed as the mean ± standard deviation of 3 to 4
larvae. Red Arabic numerals indicate the larvae selected for analysis
shown in (A). Dead larvae are indicated by red arrows. Black Arabic
numerals (sample 17 in A) signify protein bands that were excised.
The proteins identiﬁed by MS/MS analysis are listed in Table S1. The
survival rate (%) of ABPV-infected larvae was monitored throughout
the incubation time. The numbers in brackets represent the number of
survivors in relation to the total number of individuals. The total
number of larvae decreased with prolonged incubation times because
3 to 4 individuals were removed from each group at the indicated
times (p.i.) for subsequent analysis (colour ﬁgure online)
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ASP3c
Fig. 4 Comparison of humoral immune responses of bee larvae
and adults upon bacterial and viral infections. Fourth-instar larvae
(A) or newly emerged worker bees (B) were either left untreated
(n.i.), mock-infected with PBS, or challenged with 10
5 E. coli cells or
with 10
3 ABPV particles. Haemolymph samples were collected 24 h
p.i., followed by protein analysis and inhibition-zone assays. Aliquots
of 1.5 ll were applied to 15% PAA/0.1% SDS gels containing tricine
(A) or no tricine (B). Aliquots of the same samples were applied to
agar plates together with M. ﬂavus as indicator bacteria. Newly
synthesized ABPV-speciﬁc capsid proteins are indicated by red
arrowheads. The AMPs hymenoptaecin (H), defensin 1 (D), abaecin
(A) and the immune-responsive proteins carboxylesterase (CE-1),
IRp30 and peptidoglycan recognition protein-S2 (PGRP) induced
upon bacterial infection [41] are marked by red arrows. The
corresponding bands were excised from the gels, and the proteins
were identiﬁed by subsequent MS/MS analysis (colour ﬁgure online)
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123of AMPs in haemolymph samples was evaluated in the
inhibition-zone assay. Employing M. ﬂavus as Gram-
positive test bacteria revealed no antimicrobial activity in
the haemolymph collected from uninfected or ABPV-
infected larvae, whereas large inhibition zones developed
after application of samples (no. 5 and 6) derived from
larvae challenged with E. coli (Fig. 4A). Similar results
were obtained if the Gram-negative E. coli were used as
test bacteria in the inhibition-zone assay (not shown). It
should be noted that aseptic wounding with PBS sometimes
resulted in weak transient synthesis of AMPs, as described
previously [41].
Next, we compared the response of adult bees to single
infections with E. coli and ABPV. Newly emerged worker
beeswerelikewisedividedinfourgroups,eachconsistingof
20 individuals. They were kept in small cages and placed in
an incubator at 35C after artiﬁcial infection. Haemolymph
samples were collected 24 h p.i. and utilized for proteome
analysis and inhibition-zone assays. Adult bees reacted to
challenge with 10
5 E. coli cells with the synthesis of the
known AMPs hymenoptaecin and defensin1, as seen in the
corresponding haemolymph samples separated in a 15%
PAA/0.1% SDS gel (Fig. 4B). It should be mentioned that
abaecin is not visible in this particular gel. In the haemo-
lymph of adult bees, the chemosensory protein ASP3c is
present in all individuals. Since it co-migrates to almost the
samepositionashymenoptaecin(Fig. 4B,lanes7and8),we
excised the corresponding protein bands and conﬁrmed the
absenceofinducedhymenoptaecinuponABPVinfectionby
subsequent MS/MS analysis. Furthermore, three large
immune-responsive proteins were up-regulated upon injec-
tion with bacteria and, occasionally, with buffer. The three
proteins were identiﬁed previously as peptidoglycan rec-
ognition protein-S2 (PGRP-S2), a member of the carboxy-
lesterase family (CE-1), and a novel leucine-rich repeat
protein termed IRp30 [1, 41]. None of the small antimicro-
bial peptides or large immune-responsive proteins was
induced in adult bees after challenge with 10
3 ABPV par-
ticles.Instead,theonlynewcomponentsexpressedtoalarge
extent in ABPV-infected bees were the ABPV-speciﬁc
capsid proteins VP1/VP4, VP2 and VP3. The overall
absence of AMPs in adult bees 24 h after ABPV infection
was conﬁrmed in the inhibition-zone assay (Fig. 4B) and in
time course experiments shown above (Fig. 2A). In contrast
to larval haemolymph, samples originating from adult bees
sometimes resulted in inhibition zones that looked brownish
in the area where the sample was applied to the agar plate
(e.g., Fig. 4B, sample 8) but could be clearly distinguished
from ‘‘positive’’ controls (e.g., Fig. 4B, samples 5 and 6).
The dark staining possibly results from the production of
melanin. Phenoloxidase inhibitors such as phenylthiourea
and aprotinin added to the collected haemolymph samples
had no signiﬁcant effect on this phenomenon.
Challenge of young adult worker bees with ABPV does
not evoke nodulation reactions
Nodulation is a cellular immune reaction to bacterial
infection in many insects that involves interactions
between circulating haemocytes and bacteria [27] and is
also involved in responses to some viral infections [10, 20].
It was recently demonstrated by Bedick et al. [8] that this
specialized cellular defence reaction is expressed in newly
emerged worker bees artiﬁcially infected with freeze-dried
bacteria (i.e., Serratia marcescens). We have made similar
observations with adult bees challenged with viable E. coli
cells but found that bee larvae responded to bacterial
infection with a very weak nodulation reaction (unpub-
lished observation). We injected E. coli cells into the
haemocoel of young adult workers and assessed the for-
mation of nodules at selected times post-injection. The ﬁrst
melanised nodules were visible at 2 h p.i., reached a
maximum of approximately 100 nodules per bee at 6 h p.i.,
and thereafter, the total number of visible nodules
remained constant up to 48 h p.i. Figure 5A shows a
typical image of nodule formation 24 h after injection of
10
4 viable E. coli cells. It can be seen that the abdominal
tergites have been removed and the haemocoel is exposed.
Most melanised nodules are attached along the dorsal
vessel and the tracheal system. However, in three inde-
pendent series of experiments, we did not observe any
nodules at any time post-injection of 10
3 or 10
4 ABPV
particles into the haemocoel of freshly emerged worker
bees (Fig. 5B), suggesting that this cellular defence reac-
tion is not mediated by ABPV in bees.
Innate immune responses are expressed in bees
simultaneously infected with ABPV and E. coli
As reported above, a prominent humoral immune response
was not induced in bee larvae or adults upon ABPV
infection (Figs. 2, 3, 4), nor did adult worker bees respond
with a nodulation reaction to challenge with ABPV
(Fig. 5B). Hence, we asked the question whether innate
immune responses are generally suppressed in infected
individuals as a consequence of ABPV propagation. We
carried out a series of experiments with bee larvae and
adults challenged with only E. coli or ABPV or with both
pathogens together (Fig. 6).
AMPs were induced upon E. coli infection of larvae as
early as 6 h p.i. (not shown). Longer incubation times of 12
and 24 h p.i. resulted in enhanced expression of antimi-
crobial activity as deduced by increased production of
hymenoptaecin and defensin1 and the enlargement of
inhibition zones (Fig. 6A). No evidence for the production
of AMPs could be detected in ABPV-infected larvae at any
time post-injection (Figs. 3A, 6A). Simultaneous infections
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123of larvae with E. coli and ABPV did not suppress the
induction of a humoral response up to 12 h p.i., as indi-
cated by the presence of AMPs in the inhibition-zone assay
(Fig. 6A, samples 7-9). However, very little antimicrobial
activity could be detected in mixed infections at prolonged
incubation times up to 24 h p.i. (Fig. 6A, samples 15 and
16). These observations were made repeatedly in a total of
three independent series of experiments. Multiplication of
ABPV in larvae along with simultaneous E. coli infection
proceeds as in single infections, as revealed by the massive
production of ABPV-speciﬁc capsid proteins (Fig. 6A,
lanes 15 and 16), but the onset of visible virus propagation
is delayed in mixed infections.
Simultaneous infections of newly emerged adult worker
bees with 10
3 ABPV particles and 10
4 E. coli cells revealed
features that were similar but not identical to those
observed in larvae. We did not detect a reduction in the
overall antimicrobial activity in the inhibition-zone assay
up to 24 h p.i. (Fig. 6B, samples 6 and 7), but we did
observe a delay in ABPV propagation (Fig. 6B). A slightly
different picture emerged if we injected 10
4 ABPV parti-
cles and 10
5 E. coli cells simultaneously into young adult
1000 µm 500 µm
1000 µm 500 µm
A
B
Trachea
Dorsal vessel
1000 µm 500 µm
C
Fig. 5 Comparison of cellular immune responses of adult worker
bees upon bacterial and viral infections. Newly emerged worker
bees were challenged with 10
4 viable E. coli cells (A), 10
3 ABPV
particles (B), or with a mixture of the two pathogenic components
consisting of 10
4 E. coli cells and 10
3 ABPV particles (C). Groups of
10 individuals were kept in small cages for 24 h p.i. in an incubator at
35 C. Then, the abdominal tergites of the bees were removed, and the
haemocoel was inspected for the presence of melanised nodules,
which are indicated by red arrows. The average number of nodules was
108 ± 14 (A), 0 (B) and 52 ± 24 (C), respectively, expressed as the
mean ± standard deviation of ﬁve examined bees. Photomicrographs
were made with an Olympus SZX7 stereomicroscope equipped with
an Olympus UC30 camera. Magniﬁcation was 259 for the complete
abdomen and 759 for the detailed view (colour ﬁgure online)
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123worker bees. Under these experimental conditions, we did
not observe a delay in ABPV propagation, but we did
observe a reduction in antimicrobial activity (not shown).
As shown above, adult worker bees responded with the
formation of nodules upon E. coli infection (Fig. 5A),
whereas this reaction was not initiated after ABPV infec-
tion (Fig. 5B). Simultaneous injection of E. coli and ABPV
into the haemocoel of young worker bees did not suppress
the nodulation reaction completely but resulted in a
reduced number of nodules detected at 24 h p.i. (Fig. 5C).
Discussion
In connection with the recent expansion of the ectoparasitic
mite Varroa destructor in honey bee colonies, a newly
acquired virulence of several bee viruses belonging to the
family Dicistroviridae has been observed worldwide [24].
We have focused our interest on acute bee paralysis virus
(ABPV),oneofabout18beevirusesidentiﬁedsofar[2,13].
ABPV shares some antigenic and sequence similarities with
Kashmir bee virus (KBV) and Israeli acute paralysis virus
(IAPV), and together they form a distinct subgroup within
the family Dicistroviridae [9, 17, 18, 35]. Three major
featuresareofgeneralrelevanceconcerningviralinfections:
(i) the site of viral propagation within infected individuals,
(ii) the routes of viral transmission, and (iii) the defence
mechanisms initiated upon viral infection.
We have identiﬁed the haemolymph of infected bee lar-
vae and of adults as the source of massive ABPV
propagation and were able to monitor virus multiplication in
vivointhenaturalhostbyobservingcapsidproteinsynthesis
via gel electrophoretic analysis (Figs. 2A, 3A). The trans-
lation of ORF2 from an internal ribosomal entry site
(Fig. 1A) yields a precursor polypeptide of *104 kDa
(Fig. 1D) that has to be processed into functional capsid
units by three proteolytic steps (indicated as I, II and III in
Fig. 1A), two of which (I and III) are most likely generated
by the virus-encoded 3C protease. This chymotrypsin-like
cysteine protease cleaves right after a conserved glutamine
(Q) residue [18, 42]. The structural motif of the third
cleavage site separating VP4 from VP2 (cleavage site II) is
highly conserved in all dicistroviruses [52]. Yet, the corre-
sponding proteolytic activity is not known. It has been
proposed that this site is processed autocatalytically inside
the mature virion [34, 49] or that an unknown host-cell
activity is involved. We have detected a single precursor
polypeptide in ABPV-infected bee larvae and adults that is
composed of VP1 and VP4 and has been designated as VP0
(Fig. 1A) by analogy to picornaviruses [31]. This capsid
precursor is expressed at about the same time and at about
equivalent amounts as the two capsid protein units VP2 and
VP3 (Figs. 2A, 3A), indicating almost simultaneous cleav-
ages of the polyprotein precursor at processing sites II and
III. Infrequently, we observed the separate capsid protein
units VP1 and VP4 in ABPV-infected larvae at 24 h p.i.
(Figs. 3A, 4A), implying that processing step I is a late
event. This processing scheme observed in vivo in the
haemolymph of ABPV-infected bees differs from that
suggested by Tate et al. [49], who determined the ﬁrst
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Fig. 6 Responses of bee larvae and adults upon simultaneous
infection with E. coli and ABPV. Fourth-instar larvae (A) and newly
emerged worker bees (B) were left untreated (n.i.), challenged
separately with 10
4 E. coli cells and with 10
3 ABPV particles or
challenged with a mixture of 10
4 E. coli cells and 10
3 ABPV particles.
Haemolymph samples were collected at the indicated times, followed
by protein analysis and inhibition-zone assays. Survival rates [%] are
indicated below. Newly synthesized ABPV-speciﬁc capsid proteins
are indicated by arrowheads. H = hymenoptaecin, D = defensin1
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123three-dimensional crystal structure of an insect picornavirus
(i.e.,cricketparalysisvirus,CrPV)andindicatedtheorderof
capsid proteins encoded in the precursor as VP2/VP4/VP3/
VP1. This numbering appears to be misleading, because it
reﬂects neither the order ofcapsid proteins inpicornaviruses
(VP4/VP2/VP3/VP1), where numbers 1 to 4 refer to the
poliovirus capsid proteins in order of decreasing size [31],
nor to the actual sizes of CrPV capsid proteins which would
result in the genomic order VP2/VP4/VP1/VP3 (AF218039;
35). Tate et al. [49] have proposed that cleavage at site II
most likely occurs concurrently with packaging of the viral
RNAwithinthematurevirusparticlebecausetheyfoundthe
C-terminus of VP4 to be located in close proximity to the
N-terminus of VP3, i.e., within ‘‘bonding’’ distance. There
aresomereportsthatsupporttheassumptionthatcleavageat
site II is a late processing event, whereas other studies
present data that instead indicate that cleavage at site I
occurs late in infection. N-terminal sequencing of capsid
proteins obtained from puriﬁed immature Plautia stali
intestine virus (PsIV) particles revealed that a minor pre-
cursor protein of 35 kDa called VP0 had the same N-ter-
minal sequence as VP4, suggesting that VP0 is composed of
VP4 and VP2 according to the numbering of PsIV [38, 45].
On the other hand, studies of the propagation of CrPV and
drosophila C virus (DCV) in Drosophila cells revealed a
pattern similar to that observed for the multiplication of
ABPV in honey bees. Three major polypeptides were
detected early in infected cells, corresponding to two capsid
proteins and one viral precursor protein (VP0) that possibly
consisted of VP2 and VP4 [36, 37] analogous to VP1/VP4
expressed in bee larvae and adults (Figs. 2, 3).
Newly synthesized ABPV capsid proteins were clearly
visible in the haemolymph of infected bee larvae or adults
between 9 and 12 h p.i., and their amount increased rapidly
up to 24 h p.i. (Figs. 2A, 3A). The haemolymph contains
several types of cells, called haemocytes, that differ in var-
ious insects [50]. However, the prevalent cell type in all
insectsareplasmatocytes,whicharepartiallyresponsiblefor
phagocytosis of invading pathogens [28, 33]. Although we
cannotcompletelyruleoutthatABPVispropagatedinthefat
body or any other tissue and subsequently released into the
haemocoel, we think it more likely that ABPV multiplies in
free haemocytes. This assumption is supported by the
observationthatABPV capsidproteins(VP0,VP2andVP3)
were highly enriched in the cellular fraction after low-speed
centrifugation(*15,000 g)ofthetotalhaemolymphandnot
in the supernatant. In contrast, AMPs and immune-respon-
sive proteins produced in the fat body after challenge with
bacteria were foundenriched inthe supernatantfraction(not
shown). Moreover, it should be noted that we have observed
the occurrence of the ABPV-speciﬁc capsid precursor VP0
(composed of VP1 and VP4) simultaneously with capsid
unitsVP2andVP3inthehaemolymphofinfectedlarvaeand
adultbees(Figs. 2A,3A).Ifoneexcludesthepossibilitythat
aberrant virus particles are released to a great extent by any
cell type, then the haemocytes remain the likely candidates
for ABPV propagation. In adult bees acutely infected with
ABPV, the virus accumulates in the brain and hypopharyn-
geal glands [4]. Since the haemolymph circulates freely
through all body sections of the honey bee, ABPV could
reach the head after abdominal infections by two means:
either by being entrapped in haemocytes or as free virus
particles after release from disintegrating cells.
Challenge of insects with microorganisms induces cel-
lular and humoral immune responses. Nodulation is a cel-
lular immune function that is activatedby bacteria and fungi
[48],andithasbeenshownthatthisreaction isalsoinvolved
in responses to some viral infections. For example, larvae of
the endoparasitoid Pimpla turionella (Hymenoptera) and
larvae of the greater wax moth Galleria mellonella (Lepi-
doptera) challenged with bovine herpes simplex virus-1
(BHSV-1)inducednodulationreactionsinadose-dependent
manner[10,20].Newlyemergedadultbeesrespondedwitha
pronounced production of melanised nodules after E. coli
infection(Fig. 5A);however,nonodulesatallweredetected
upon ABPV infection (Fig. 5B), suggesting that this type of
cellular immune response is not activated against ABPV in
bees. Moreover, our data indicate that honey bee larvae and
adults also do not trigger a general humoral immune
response upon ABPV infection – in contrast to the reaction
observed after challenge with E. coli. ABPV-infected indi-
viduals did not produce elevated levels of speciﬁc AMPs
such as hymenoptaecin, and we did not detect any general
antimicrobial activity in the inhibition-zone assay (Fig. 4).
ExpressionofhymenoptaecininbeesismediatedbytheImd
signalling cascade, as revealed by RNA interference studies
[47]. Hence, the absence of hymenoptaecin in ABPV-
infected cells implies that the Imd pathway initiating a
humoral immune response is not induced upon ABPV
infection. These results are consistent with studies carried
out by Sabatier et al. [43] and Costa et al. [15], who did not
detect any of the known AMPs in the haemolymph of Dro-
sophilaﬂieschallengedwithDCVorCrPV(twomembersof
the family Dicistroviridae), supporting our ﬁnding that viral
infections of insects do not induce the same innate immune
response as bacterial infections. As mentioned above, the
intrinsic defence mechanism based on RNA interference
plays a major role in antiviral immunity in insects. Future
studiesareofutmostimportancetorevealtheroleofRNAiin
the antiviral response of honey bees.
The failure to detect AMPs in virus-infected individuals
could actually mean that humoral immune responses are
suppressed by the virus. To address this question, we have
carried out numerous experiments with simultaneous
injections of E. coli and ABPV into larvae or adult bees
(Fig. 6). We observed mutual detrimental effects in mixed
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123infections on both levels, i.e., the expression of antimi-
crobial peptides as well as the onset and extent of ABPV
propagation. The impact on either response was dependent
to some degree on the injected individual dose of E. coli
cells and ABPV particles in mixed infections. But we
detected antimicrobial activities and speciﬁc AMPs in the
haemolymph of individuals challenged with both types of
pathogens, indicating that the strong humoral immune
response induced after bacterial challenge is not suppressed
completely by viral infection (Fig. 6).
The high yield of ABPV particles produced in the very
ﬁrst 12 h p.i. in bee larvae and adults clearly precedes any
noticeable responses of the infected individuals either at the
molecular level or in the occurrence of pathological symp-
toms: the overall haemolymph protein pattern remained
essentially unchanged in this early infection period, and
pathological effects were also not yet visible (Figs. 2, 3).
Later on, the responses of sick bee larvae and adults differed
strikingly. Protein analysis of haemolymph samples col-
lected from ABPV-infected adult bees revealed no major
alterations throughout the entire infection process—apart
from the massive synthesis of ABPV capsid proteins
(Fig. 2A), whereas in the haemolymph of ABPV-infected
larvae a broad spectrum of proteins was induced between 12
and 24 h p.i., which included various heat-shock proteins
(Table S1). Finally, the major larva-speciﬁc haemolymph
proteins such as hexamerins 70a and 70b were degraded
(Fig. 3A; Table S1). The impressive change in the haemo-
lymph protein pattern coincided with a dramatic change in
the appearance of ABPV-infected bee larvae (Fig. 3C). The
quick andalmostsimultaneous deadly collapse ofbeelarvae
upon ABPV infection combined with these striking features
indicate that in vitro-cultured bee larvae are convenient
model organisms for (i) reliable and quick bioassays to test
ABPV infectivity, (ii) the study of host-virus interactions,
and (iii) the screening of antiviral compounds [22].
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